[1]Lee WM.Hepatitis B Virus infections[J].NEngl J Med, 1997, 337 (24) ∶1733-45.
|
[2]Liaw YF, Leung N, Guan R, et al.Asian-Pacific consensus state-ment on the management of chronic hepatitis B:an update[J].JGastroenterol Hepatol, 2003, 18 (3) ∶239-45.
|
[3] 中华医学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) ∶324-329.
|
[4] 中华医学会.慢性乙型肝炎防治指南[J].中华肝脏病杂志, 2005, 13 (12) ∶881-891.
|
[5] 汪俊韬.各类病毒性肝炎治疗方案的选择[J].临床肝胆病杂志, 1994, 10 (1) ∶3.
|
[6]Lau DT, Khokhar MF, Doo E, et al.Long-term therapy of chronichepatitis B with lamivudine[J].Hepatology, 2000, 32 (4) ∶828-34.
|
[7]孔增科, 周海平, 付正良.常用中药药理与临床应用[M].内蒙古:内蒙古科学技术出版社, 2004∶179-181.
|
[1] | Jiayi ZHANG, Shuyan CHEN, Hong YOU. Expanding initial anti-HBV therapy for chronic hepatitis B: Reducing the treatment threshold of alanine aminotransferase[J]. Journal of Clinical Hepatology, 2023, 39(1): 27-30. doi: 10.3969/j.issn.1001-5256.2023.01.004 |
[2] | Hui ZHUANG. Expanding the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2023, 39(1): 10-13. doi: 10.3969/j.issn.1001-5256.2023.01.001 |
[3] | Branch of Hepatobiliary Diseases, Chinese Association of Chinese Medicine. Expert consensus for clinical application of Wuling capsule(pill) in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2022, 38(9): 1986-1989. doi: 10.3969/j.issn.1001-5256.2022.09.007 |
[6] | Zhu YuJia. Effect of Anti-HB transfer factor and Adefovir Combination Therapy on Patients with Chronic-Hepatitis B and Influence on HBV DNA[J]. Journal of Clinical Hepatology, 2008, 24(5): 338-340. |
[7] | Luo WeiMin, Zhang YingChun, Liu ZhongJing. Clinical Observation about Entecavir in Treating Chronic Hepatitis B at the Initial Stage.[J]. Journal of Clinical Hepatology, 2008, 24(1): 26-28. |
[10] | Wang Yuan, Yu LiangKe, Cao KeYong, Zhang RuiFeng, Zhang YuZhong. The efficacy of HBeAg-positive chronic hepatitis B with Adefovir dipivoxil and Ganluoxin pills in 24 weeks[J]. Journal of Clinical Hepatology, 2007, 23(6): 428-429. |
[16] | Xing WenBin, An Jie, Zheng Mei, Liu LiNa, Qin XiaoBo, Lu: Shen. The Expression of Fas、FasL in the Liver Tissue of Chronic Hepstitis B[J]. Journal of Clinical Hepatology, 2002, 18(5): 275-276. |
[18] | Zhang Yi, Pu ChunWen, Gong HangYu, Sun Yong, Zhang Jian, Lin QiMin. Preliminary Study on Specific Active Immunotherapy in the Treatment of Chronic Hepatitis B.[J]. Journal of Clinical Hepatology, 2001, 17(3): 159-160. |